Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

NCT06800092 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT06800092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06800092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
June 15, 2027
Completion date
June 1, 2030
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer